About usSign in
Status
ACTIVE
Global HQ
Norwood, United States
Countries of investment
  • USA
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Fintech
  • Blockchain
  • Crypto
  • AI
  • Data Services
About
Advent Life Sciences is a leading venture Capital firm based in London, United Kingdom and Massachusetts, United States. They have been investing in innovative life sciences companies since 2006. The companies in their portfolio have discovered and developed fourteen approved medicines and products, benefiting patients, physicians, and investors. The firm specializes in leading venture investments in the life sciences industry and has a highly experienced team with a longstanding track record of entrepreneurial and investment success. They work in close partnership with their portfolio companies and utilize a strong network to source the best opportunities and attract worldclass talent.
Min check size
$250K
Max check size
$5M
Fund size
NPS

Investment Thesis

Advent Life Sciences focuses on investing in innovative life sciences companies, leveraging their deep technical, commercial, and financial expertise to source the best opportunities and attract worldclass talent.
Lead investor
Co Invest
Number of exits
Preferred contact method

Advent Life Sciences Contacts Information

Primary contact

Secondary contact

Portfolio

Levicept

Beacon Therapeutics

Amphista Therapeutics

Ventus Medical

Centessa Pharmaceuticals

AviadoBio

Almirall

Eloxx Pharmaceuticals

Argá Medtech

Curve Therapeutics

Aleta Biotherapeutics

Orphalan

Bayer

Aura Biosciences

Artax

Cancer Research UK

Bristol Myers Squibb

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp